Results of a phase II trial involving Lenalidomide following allogeneic stem cell transplant for relapsed CLL.
Home / Resource Library / Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation